Randomised Controlled Non-Inferiority Study of Dose Reduction and Withdrawal of Adalimumab and Etanercept in Rheumatoid Arthritis.

被引：0
|
作者：
van Herwaarden, Noortje [1 ]
van der Maas, Aatke [1 ]
Minten, Michiel [1 ]
van den Hoogen, Frank H. J. [2 ,3 ]
van Vollenhoven, Ronald F. [4 ]
Bijlsma, Johannes W. J. [5 ]
van den Bemt, Bart [1 ]
den Broeder, Alfons A. [1 ]
机构：
[1] Sint Maartensklin, Nijmegen, Netherlands
[2] Sint Maartensklin, Rheumatol Ctr, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[4] Karolinska Inst, Unit Clin Therapy Res ClinTrid, Stockholm, Sweden
[5] Univ Med Ctr Utrecht, Utrecht, Netherlands
来源：
ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1843
引用
收藏
页码：S810 / S811
页数：2
相关论文
共 50 条
  • [21] Falling in the margin Randomised controlled trials with a non-inferiority design
    Middleton, Lee Jonathan
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2021, 128 (12) : 1916 - 1916
  • [22] Evaluation of the efficacy and safety of a herbal formulation for rheumatoid arthritis - A non-inferiority randomized controlled trial
    Ansari, Umme Ammara Maqbool Ahmad
    Uddin, Qamar
    Husain, Nazim
    Ahmad, Tasleem
    Fatima, Syeda Hajra
    Minhajuddin, Ahmed
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 325
  • [23] FINDING THE OPTIMAL TREATMENT STRATEGY FOR DISEASE ACTIVITY-GUIDED DOSE REDUCTION OF ADALIMUMAB AND ETANERCEPT IN RHEUMATOID ARTHRITIS: A MODELLING STUDY
    Verhoef, L. M.
    Bos, D. P.
    van den Ende, C. H.
    van den Hoogen, F. H.
    Fautrel, B.
    Hulscher, M. E.
    Kievit, W.
    den Broeder, A. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 323 - 323
  • [24] Finding the Optimal Treatment Strategy for Disease Activity-Guided Dose Reduction of Adalimumab and Etanercept in Rheumatoid Arthritis: A Modelling Study
    Bos, D. P. G.
    Verhoef, L. M.
    van den Ende, C. H. M.
    van den Hoogen, F. H. J.
    Fautrel, Bruno
    Hulscher, M. E. J. L.
    Kievit, W.
    Den Broeder, A. A.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [25] Clinical and economic efficiency to reduce dose etanercept and adalimumab in patients with rheumatoid arthritis
    Rosalía Martínez-Pérez
    Sergio Rodríguez-Montero
    Alejandro Muñoz
    Julia Uceda
    Mario León
    Francisco Gallo
    Maria Luisa Velloso
    José Luis Marenco
    Journal of Translational Medicine, 10 (Suppl 3)
  • [26] ETANERCEPT DOSE REDUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS - A PILOT STUDY IN SOUTH WALES
    Duffill, S.
    Kia, S.
    Amos, N.
    Thomas, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 500 - 500
  • [27] A smartphone intervention for adolescent obesity: study protocol for a randomised controlled non-inferiority trial
    O'Malley, Grace
    Clarke, Mike
    Burls, Amanda
    Murphy, Sinead
    Murphy, Nuala
    Perry, Ivan J.
    TRIALS, 2014, 15
  • [28] Comment on l'Ami et al titled 'Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial'
    den Broeder, Alfons A.
    van den Bemt, Bart J. F.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (10)
  • [29] A smartphone intervention for adolescent obesity: study protocol for a randomised controlled non-inferiority trial
    Grace O’Malley
    Mike Clarke
    Amanda Burls
    Sinéad Murphy
    Nuala Murphy
    Ivan J Perry
    Trials, 15
  • [30] Normal saline for children with bronchiolitis: study protocol for a randomised controlled non-inferiority trial
    Schmidt, Marika Nathalie
    Daugberg, Rie
    Nygaard, Ulrikka
    Nielsen, Xiaohui Chen
    Chawes, Bo
    Rytter, Maren Heilskov
    Schoos, Ann-Marie Malby
    BMJ PAEDIATRICS OPEN, 2024, 8 (01)
12345